Brain tumor combo shows promise in early trial
Disease control
Recruiting now
This study tests a combination of two drugs (ATRA and retifanlimab) in people with a specific type of brain tumor (IDH-mutant glioma) that has returned after standard treatment. The goal is to see if this combo can shrink tumors or slow their growth by helping the immune system a…
Phase: PHASE2 • Sponsor: Stephen Bagley, MD, MSCE • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC